Emotion regulation and visual attention in body dysmorphic disorder: a multimodal study using EEG, GSR, and eye-tracking

身体畸形恐惧症患者的情绪调节和视觉注意力:一项采用脑电图、皮肤电反应和眼动追踪的多模态研究

阅读:1

Abstract

BACKGROUND: Body Dysmorphic Disorder (BDD) is a psychiatric condition characterized by obsessive preoccupation with perceived physical flaws, often accompanied by emotional dysregulation and attentional biases. Despite increasing clinical recognition, the neurophysiological and attentional mechanisms underlying BDD remain poorly understood. METHODS: This study employed a multimodal experimental design to compare individuals with BDD (n = 27) and healthy controls (n = 27). Participants completed standardized psychometric assessments and were exposed to emotionally valenced facial and body-related images while undergoing electroencephalography (EEG), galvanic skin response (GSR), and eye-tracking. Group-by-valence interactions were analyzed using mixed-model ANOVAs. RESULTS: The BDD group showed significantly higher depression, anxiety, body image disturbance, and suppression scores, alongside reduced cognitive reappraisal and self-efficacy. EEG analyses revealed increased N170 amplitudes, attenuated P300 amplitudes, and greater right-sided frontal alpha asymmetry, suggesting early hypervigilance, reduced evaluative processing, and affective withdrawal. GSR data indicated heightened sympathetic arousal and delayed physiological recovery. Eye-tracking data descriptively indicated gender-specific attentional patterns within the BDD group, with females allocating greater visual attention to facial and lower-body regions and males showing increased fixation on muscular upper-body features; such patterns were not observed in the control group. CONCLUSION: BDD is associated with dysregulated multisystem responses to appearance-related stimuli, characterized by neural hyperreactivity, impaired cognitive-emotional regulation, and gender-related patterns of visual attention. These findings support the utility of integrating psychophysiological and attentional markers into individualized assessment and intervention strategies for BDD. CLINICAL TRIAL NUMBER: Not applicable.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。